| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/30/2003 | US20030022284 Polypeptide for use in the diagnosis and treatment of kidney defects |
| 01/30/2003 | US20030022283 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 01/30/2003 | US20030022282 Nucleotide sequences coding polypeptide for use in the treatment of nervous system, urogenital, psychotherapeutics, gastrointestinal, reproduction and sleep disorders |
| 01/30/2003 | US20030022279 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of kidney and cell proliferation disorders |
| 01/30/2003 | US20030022277 Nucleotide sequences coding polypeptide or use in the treatment of eating disorders |
| 01/30/2003 | US20030022276 Dendritic enriched secreted lymphocyte activation molecule |
| 01/30/2003 | US20030022275 Human nk-3 related prostate specific gene-1 |
| 01/30/2003 | US20030022267 Monitoring the physiological effect of a composition on animal; obtain animal, administer moulator, record physiological adjustments |
| 01/30/2003 | US20030022257 Nucleotide sequences coding polypeptid for use in the diagnosis and prevention of lung cancer |
| 01/30/2003 | US20030022232 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 01/30/2003 | US20030022229 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | US20030022211 Nucleotide sequences coding polypeptide for use in diagnosis and prevention of psychological and nervous system disorders |
| 01/30/2003 | US20030022210 Induction of tissue repair and/or regeneration; obtain cells, incubate with lymphocytes, monitor regeneration of tissues |
| 01/30/2003 | US20030022209 ADSLs as modifiers of the p53 pathway and methods of use |
| 01/30/2003 | US20030022198 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 01/30/2003 | US20030022187 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022186 Novel human G-protein coupled receptor, hgprbmy18, expressed highly in pituitary gland and colon carcinoma cells |
| 01/30/2003 | US20030022185 Secreted protein HLHFP03 |
| 01/30/2003 | US20030022183 Novel human G-protein coupled receptor, HGPRBMY7, expressed highly in spinal cord |
| 01/30/2003 | US20030022181 Streptococcus pneumoniae antigens |
| 01/30/2003 | US20030022178 Identification of sortase gene |
| 01/30/2003 | US20030022161 Diagnosing mammary gland cancer in humans; obtain ductal fluid sample, monitor marker gene product expression, amplified concentrations of marker products indicates cancer |
| 01/30/2003 | US20030022158 Peptide for use in the treatment of viral infection |
| 01/30/2003 | US20030021840 High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same |
| 01/30/2003 | US20030021838 Anticancer agents; vaccines; induction immunology response |
| 01/30/2003 | US20030021821 Collagen or collagen-like peptide containing polymeric matrices |
| 01/30/2003 | US20030021816 Antiinflammation agents, antiscarring agent; administering immunosuppressant |
| 01/30/2003 | US20030021810 Chlorotoxin inhibition of cell invasion, cancer metastasis, angiogenesis and tissue remodeling |
| 01/30/2003 | US20030021808 Cd40 ligand adjuvant for respiratory syncytial virus |
| 01/30/2003 | US20030021797 Localization of major peptide autoepitopes for nucleosome specific T cells of systemic lupus erythematosus |
| 01/30/2003 | US20030021795 Administering antibody; determination binding to peptide |
| 01/30/2003 | US20030021794 Heat shock protein-based vaccines and immunotherapies |
| 01/30/2003 | US20030021792 Quantitative analysis; immunosuppressants, anticoagulants |
| 01/30/2003 | US20030021788 Novel human STRA6-like protein and nucleic acids encoding the same |
| 01/30/2003 | US20030021787 In situ therapy; sustained release |
| 01/30/2003 | US20030021785 Use of rank antagonists to treat cancer |
| 01/30/2003 | US20030021781 Administering antibodies |
| 01/30/2003 | US20030021779 Immunology response; monoclonal antibodies |
| 01/30/2003 | US20030021776 Regulation of angiogenesis with zinc finger proteins |
| 01/30/2003 | US20030021775 Control activation using enzymes; therapy for skin defects |
| 01/30/2003 | US20030021768 Viral mutants that selectively replicate in targeted human cancer cells |
| 01/30/2003 | US20030021767 Recombinant p53 adenovirus methods and compositions |
| 01/30/2003 | US20030021766 Nucleic acid mucosal immunization |
| 01/30/2003 | US20030021765 Polymer conjugates of interferon beta-1a and uses |
| 01/30/2003 | US20030021764 Methods of treatment of neurological diseases by interferon antagonists |
| 01/30/2003 | US20030021763 Method for the treatment and/or prophylaxis of diseases caused by IL-12 |
| 01/30/2003 | CA2454427A1 A novel g protein-coupled receptor, gave8 |
| 01/30/2003 | CA2454423A1 Method and reagents for identifying gene targets for treating breast cancer |
| 01/30/2003 | CA2454419A1 Invasion complex and methods of targeting |
| 01/30/2003 | CA2454418A1 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/30/2003 | CA2454357A1 An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration |
| 01/30/2003 | CA2454345A1 Anti-tumor activity from reptile serum |
| 01/30/2003 | CA2454189A1 High protein, bowman-birk inhibitor concentrate and process for its manufacture |
| 01/30/2003 | CA2454185A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 01/30/2003 | CA2453987A1 Dolastatin 10 derivatives |
| 01/30/2003 | CA2453986A1 Glycoprotein vi fusion proteins |
| 01/30/2003 | CA2453967A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453965A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453720A1 A salt/ion pair medicinal aerosol formulation |
| 01/30/2003 | CA2453655A1 Novel human proton-gated channels |
| 01/30/2003 | CA2453567A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/30/2003 | CA2453478A1 Agent for treatment of cerebral ischemic diseases |
| 01/30/2003 | CA2453475A1 Methods of treating liver fibrosis |
| 01/30/2003 | CA2453249A1 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | CA2452677A1 Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides |
| 01/30/2003 | CA2452653A1 Silencing of gene expression by sirna |
| 01/30/2003 | CA2452556A1 Protein-containing foodstuff comprising a coss-linking enzyme and a hydrocolloid |
| 01/30/2003 | CA2452518A1 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | CA2452421A1 Anti-microbial targeting chimeric pharmaceutical |
| 01/30/2003 | CA2452322A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/30/2003 | CA2451104A1 Electro-medical device for use with biologics |
| 01/29/2003 | EP1279744A2 Identification and use of molecules implicated in pain |
| 01/29/2003 | EP1279738A1 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 01/29/2003 | EP1279733A1 Nucleic acids and polypeptides involved in the predisposition to infection to human papilloma virus, to epidermodysplasia verruciformis and/or to psoriasis |
| 01/29/2003 | EP1279731A1 Process for the development of binding mini-proteins |
| 01/29/2003 | EP1279729A1 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening inhibitors of these factors and the inhibitors |
| 01/29/2003 | EP1279678A1 Gag antigen and other orf fragments of lav virus. Use for the detection of lav infection and in immunogenic compositions |
| 01/29/2003 | EP1279677A1 Gd3-mimetic peptides |
| 01/29/2003 | EP1279404A1 Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases |
| 01/29/2003 | EP1279403A1 Pernasally absorbable insulin preparations |
| 01/29/2003 | EP1279039A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 01/29/2003 | EP1278874A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/29/2003 | EP1278869A2 Proteases |
| 01/29/2003 | EP1278868A2 Novel mutated form of arginine deiminase |
| 01/29/2003 | EP1278859A2 Human protein kinases and protein kinase-like enzymes |
| 01/29/2003 | EP1278858A2 46743 and 27417, novel human acyltransferase family members and uses therefor |
| 01/29/2003 | EP1278853A2 Listeria monocytogenes genome, polypeptides and uses |
| 01/29/2003 | EP1278849A2 Thrombopoietin receptor modulating peptide |
| 01/29/2003 | EP1278846A2 Cytoskeleton-associated proteins |
| 01/29/2003 | EP1278845A2 Cellular regulators of infectious agents and methods of use |
| 01/29/2003 | EP1278843A2 Rna metabolism proteins |
| 01/29/2003 | EP1278842A2 Dna encoding the prost 03 polypeptide |
| 01/29/2003 | EP1278837A2 Internal de novo initiation sites of the hcv ns5b polymerase and use thereof |
| 01/29/2003 | EP1278830A2 Identification and uses of a hyaluronan receptor |
| 01/29/2003 | EP1278829A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 01/29/2003 | EP1278828A1 Activation of pure prothrombin to thrombin with sodium citrate |
| 01/29/2003 | EP1278827A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 01/29/2003 | EP1278826A1 Novel proteins |
| 01/29/2003 | EP1278777A2 G protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/29/2003 | EP1278775A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |